Genetic Testing for Cancer Risk

GENETIC2 trials

Sponsors

City of Hope Medical Center, Mayo Clinic

Conditions

Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmPancreatic Carcinoma

Early Phase 1

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Active, not recruitingNCT05868486

City of Hope Medical CenterHematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

Start: 2022-05-20End: 2026-10-19Updated: 2026-01-02

Unknown Phase

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Enrolling by invitationNCT06744595

Mayo ClinicPancreatic Carcinoma

Start: 2025-02-12End: 2026-06-30Target: 50Updated: 2026-06-04

Related Papers

Feasibility of a cancer screening program using multicancer early detection testing and whole‐body magnetic resonance imaging in a high‐risk population

Cancer2025-01-012 citations

Effect of cancer screening with multi-cancer early detection testing and whole body MRI on cancer worry in a high-risk population.

Journal of Clinical Oncology2024-06-01